Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to -$236000.0.

  • Gyre Therapeutics' Other Working Capital Changes rose 4070.35% to -$236000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 24873.15%. This contributed to the annual value of -$816000.0 for FY2024, which is 7251.59% down from last year.
  • Per Gyre Therapeutics' latest filing, its Other Working Capital Changes stood at -$236000.0 for Q3 2025, which was up 4070.35% from -$5.8 million recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Other Working Capital Changes registered a high of $5.5 million during Q1 2025, and its lowest value of -$5.9 million during Q4 2021.
  • Moreover, its 5-year median value for Other Working Capital Changes was $14729.0 (2023), whereas its average is -$306028.7.
  • Data for Gyre Therapeutics' Other Working Capital Changes shows a peak YoY increase of 1241848.2% (in 2024) and a maximum YoY decrease of 280215.22% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Gyre Therapeutics' Other Working Capital Changes stood at -$5.9 million in 2021, then soared by 87.42% to -$743000.0 in 2022, then surged by 141.18% to $306000.0 in 2023, then plummeted by 949.35% to -$2.6 million in 2024, then surged by 90.92% to -$236000.0 in 2025.
  • Its last three reported values are -$236000.0 in Q3 2025, -$5.8 million for Q2 2025, and $5.5 million during Q1 2025.